Patients who were clinically- suspected with high / low- grade glioma
Conditions
Interventions
185 MBq/2 mL when calibrated) was administered intravenously into, for example, the arm, then flushed with physiological saline. The radiation dosages administered were regulated by the time of admini
Sponsors
Nihon Medi-Physics Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who were clinicaly-suspected with high / low- grade glioma by the clinical sign / course and MRI exam are to have the surgical removal of the tumor.
Exclusion criteria
Exclusion criteria: -Patients who received treatment for glioma. -Patients who received chemotherapy for malignant tumor within the last 5 years. -Patients who are pregnant, lactating or possibly pregnant. -Patients who have hepatic or renal dysfunction. -Patients with Karnofsky performance status below 40%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety efficacy Efficacy: positive-predictive value of PET imaging in the regions which are not visualized by contrast T1-weighted MRI Safety: subjective/objective symptoms, electrocardiogram exam, vital signs, clinical tests | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy Efficacy: range of administered radioactivity, range of starting time for PET imaging, search for semiquantitative index | — |
Countries
Japan
Outcome results
None listed